Cameron Gray

Insider Reports History

Location
Boston, MA
Signature
/s/ Cameron Gray by Colin Sandercock attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cameron Gray:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cue Biopharma, Inc. Director Common Stock 687,049 $1,896,255 $2.76 14 Jun 2022 Direct
Cue Biopharma, Inc. Director Warrants 0 14 Jun 2022 Direct

Insider Reports Filed by Cameron Gray

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CUE Cue Biopharma, Inc. 14 Jun 2022 3 +$1.3 4 Director 16 Jun 2022, 16:01
CUE Cue Biopharma, Inc. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 19:21